These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 36628839)

  • 1. A very late onset AChR and MuSK double positive myasthenia gravis: a case description and literature review.
    Pugliese A; Nicocia G; Messina S; Toscano A; Rodolico C
    Neuromuscul Disord; 2023 Feb; 33(2):145-147. PubMed ID: 36628839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AChR myasthenia gravis switching to MuSK or double antibody positive myasthenia gravis in two children and literature review.
    Lu Y; Ran H; Yang W; Ma Q; Qiu L; Ou C; Chen P; Lin Z; Liu W
    Neuromuscul Disord; 2020 Jul; 30(7):534-538. PubMed ID: 32387283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical characteristics and outcomes of myasthenia gravis patients with double positive antibodies against acetylcholine receptor and muscle-specific tyrosine kinase].
    Lu YR; Yu L; Ma Q; Chen P; Qiu L; Ou CY; Lin ZZ; Liu WB
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(13):942-947. PubMed ID: 35385966
    [No Abstract]   [Full Text] [Related]  

  • 4. AChR-and MuSK-positive myasthenia gravis: Double trouble.
    Zouvelou V; Psimenou E
    J Neuroimmunol; 2020 Nov; 348():577364. PubMed ID: 32916523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis.
    Damato V; Spagni G; Monte G; Woodhall M; Jacobson L; Falso S; Smith T; Iorio R; Waters P; Irani SR; Vincent A; Evoli A
    J Neurol Neurosurg Psychiatry; 2022 Sep; 93(9):995-1000. PubMed ID: 35835469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of long-term post-thymectomy outcome of anti-AChR-positive, anti-AChR-negative and anti-MuSK-positive patients with non-thymomatous myasthenia gravis.
    Ponseti JM; Caritg N; Gamez J; López-Cano M; Vilallonga R; Armengol M
    Expert Opin Biol Ther; 2009 Jan; 9(1):1-8. PubMed ID: 19063688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-AChR, MuSK, and LRP4 antibodies coexistence: A rare and distinct subtype of myasthenia gravis from Indian subcontinent.
    Bokoliya SC; Kumar VP; Nashi S; Polavarapu K; Nalini A; Patil SA
    Clin Chim Acta; 2018 Nov; 486():34-35. PubMed ID: 30006288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
    Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
    Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody profile may predict outcome in ocular myasthenia gravis.
    Galassi G; Mazzoli M; Ariatti A; Kaleci S; Valzania F; Nichelli PF
    Acta Neurol Belg; 2018 Sep; 118(3):435-443. PubMed ID: 29858757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switch to double positive late onset MuSK myasthenia gravis following thymomectomy in paraneoplastic AChR antibody positive myasthenia gravis.
    Jordan B; Schilling S; Zierz S
    J Neurol; 2016 Jan; 263(1):174-6. PubMed ID: 26645394
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis.
    Vincent A; Leite MI
    Curr Opin Neurol; 2005 Oct; 18(5):519-25. PubMed ID: 16155434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin.
    Cortés-Vicente E; Gallardo E; Martínez MÁ; Díaz-Manera J; Querol L; Rojas-García R; Illa I
    JAMA Neurol; 2016 Sep; 73(9):1099-104. PubMed ID: 27379450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MuSK Myasthenia Gravis Presenting with Bilateral Vocal Cord Abduction Paresis: A Case Report and Literature Review.
    Santilli A; Stitt D
    Neurologist; 2021 Sep; 26(5):175-177. PubMed ID: 34491934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle histopathology in myasthenia gravis with antibodies against MuSK and AChR.
    Martignago S; Fanin M; Albertini E; Pegoraro E; Angelini C
    Neuropathol Appl Neurobiol; 2009 Feb; 35(1):103-10. PubMed ID: 19187062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia gravis with muscle-specific tyrosine kinase antibodies: A narrative review.
    Morren J; Li Y
    Muscle Nerve; 2018 Sep; 58(3):344-358. PubMed ID: 29461627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic hyperactivity in patients with myasthenia gravis with MuSK antibodies: A neurophysiological study.
    Modoni A; Mastrorosa A; Spagni G; Evoli A
    Clin Neurophysiol; 2021 Aug; 132(8):1845-1849. PubMed ID: 34147009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ["Seronegative" myasthenia gravis and antiMuSK positive antibodies: description of Spanish series].
    Illa I; Díaz-Manera JA; Juárez C; Rojas-García R; Molina-Porcel L; Aleu A; Pradas J; Gallardo E
    Med Clin (Barc); 2005 Jun; 125(3):100-2. PubMed ID: 15989843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MuSK-positive myasthenia gravis is rare in the Polish population.
    Kostera-Pruszczyk A; Kamińska A; Dutkiewicz M; Emeryk-Szajewska B; Strugalska-Cynowska MH; Vincent A; Kwieciński H
    Eur J Neurol; 2008 Jul; 15(7):720-4. PubMed ID: 18494794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis.
    Nakata R; Motomura M; Masuda T; Shiraishi H; Tokuda M; Fukuda T; Ando T; Yoshimura T; Tsujihata M; Kawakami A
    Eur J Neurol; 2013 Sep; 20(9):1272-6. PubMed ID: 23679930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.